JP Morgan Chase
TBIO

JP Morgan Chase’s Translate Bio, Inc. Common Stock TBIO Stock Holding History

JP Morgan Chase’s Portfolio TBIO Stock Details TBIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-50,000
Closed -$922K – 6515
2020
Q4 		$922K Hold
50,000
– – ﹤0.01% 4018
2020
Q3 		$681K Buy
+50,000
New +$771K ﹤0.01% 3848

JP Morgan Chase's TBIO Position: Q3 2021 in Review

JP Morgan Chase sold out of Translate Bio, Inc. Common Stock (TBIO) in Q3 2021, closing a stake of 1,480,611 shares — an estimated $40.8M sold.

JP Morgan Chase first reported a position in TBIO in Q3 2018 and held it in 12 quarters. The position peaked at $40.8M in Q2 2021. 0 funds tracked by Wall St. Rank hold TBIO as of Q3 2021.

  • JP Morgan Chase reported no remaining Translate Bio, Inc. Common Stock position as of Q3 2021 after selling out during the quarter.
  • JP Morgan Chase sold 1,480,611 Translate Bio, Inc. Common Stock shares in Q3 2021, an estimated $40.8M.
  • JP Morgan Chase first reported a position in Translate Bio, Inc. Common Stock in Q3 2018 and held it in 12 quarters.
  • JP Morgan Chase's Translate Bio, Inc. Common Stock position peaked at $40.8M in Q2 2021.
  • 0 funds tracked by Wall St. Rank held Translate Bio, Inc. Common Stock as of Q3 2021.

Based on JP Morgan Chase's 13F filing for Q3 2021, filed 12 Nov 2021.